Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Rigvir®"'
Autor:
Manfred Sneps-Sneppe, Dmitry Namiot
Publikováno v:
Proceedings of the XXth Conference of Open Innovations Association FRUCT, Vol 34, Iss 2, p 289 (2023)
Oncolytic viral therapy is a promising approach to cancer treatment. The first oncolytic virus in the world was the genetically unmodified ECHO-7 strain enterovirus RIGVIR, which was approved in Latvia in 2004 for the treatment of skin melanoma. Our
Externí odkaz:
https://doaj.org/article/5af2840d9a734441a56cf26c5ae960a8
Publikováno v:
Toxicology Reports, Vol 8, Iss , Pp 230-238 (2021)
The oncolytic ECHO-7 virus Rigvir was registered in Latvia in 2004 and later in Georgia, Armenia and Uzbekistan. No severe adverse events have been observed. During drug development good laboratory practice (GLP) pre-clinical toxicology studies are g
Externí odkaz:
https://doaj.org/article/2093913a2eed4b468b9173a437acf750
Autor:
Elizabete Pumpure, Eva Dručka, Dana Kigitoviča, Raimundas Meškauskas, Sergejs Isajevs, Ineta Nemiro, Agnija Rasa, Evija Olmane, Tatjana Zablocka, Pēteris Alberts, Simona Doniņa
Publikováno v:
Clinical Case Reports, Vol 8, Iss 8, Pp 1538-1543 (2020)
Abstract Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression‐free survival are good.
Externí odkaz:
https://doaj.org/article/b5343f8dc6e245e9b9688295ac08bda0
Publikováno v:
BMC Research Notes, Vol 13, Iss 1, Pp 1-6 (2020)
Abstract Objective Uveal melanoma is a rare intraocular malignancy. Half of the patients diagnosed will develop metastases within 10 to 30 years, most commonly in the liver. Although there has been a significant development in the treatment of melano
Externí odkaz:
https://doaj.org/article/5d2128fa0a7e44849281357fc8c14473
Autor:
Linda Brokāne, Inta Jaunalksne, Andra Tilgase, Evija Olmane, Donatas Petroška, Agnija Rasa, Pēteris Alberts
Publikováno v:
Clinical Case Reports, Vol 7, Iss 6, Pp 1191-1196 (2019)
Abstract A 35‐year‐old male patient was diagnosed with stage IIC skin melanoma that rapidly progressed after surgery. Treatment was continued with radiotherapy, which did not stop further spread of disease and the patient was put on a combination
Externí odkaz:
https://doaj.org/article/a3498975670446ecb292bde6385c8f1f
Publikováno v:
Viruses, Vol 14, Iss 3, p 525 (2022)
Rigvir® is a cell-adapted, oncolytic virotherapy enterovirus, which derives from an echovirus 7 (E7) isolate. While it is claimed that Rigvir® causes cytolytic infection in several cancer cell lines, there is little molecular evidence for its oncol
Externí odkaz:
https://doaj.org/article/b2f82f3273be4e4ab94a51ee7884a4b9
Autor:
Andra Tilgase, Evija Olmane, Jurijs Nazarovs, Linda Brokāne, Romualds Erdmanis, Agnija Rasa, Pēteris Alberts
Publikováno v:
Case Reports in Gastroenterology, Vol 12, Iss 2, Pp 457-465 (2018)
Colorectal cancer is one of the most commonly diagnosed cancers worldwide. The treatment consists of surgical resection, systemic chemotherapy, and new biological agents. One more recently emerging treatment option is oncolytic virotherapy. Although
Externí odkaz:
https://doaj.org/article/e4034e7a5560461daa3b0850eafe0566
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Simona Doniņa, Ineta Nemiro, Elizabete Pumpure, Pēteris Alberts, Raimundas Meskauskas, Agnija Rasa, Dana Kigitoviča, Tatjana Zablocka, Evija Olmane, Sergejs Isajevs, Eva Dručka
Publikováno v:
Clinical Case Reports, Vol 8, Iss 8, Pp 1538-1543 (2020)
Clinical Case Reports
Clinical Case Reports
Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression‐free survival are good.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67af5a19198920d8201ab786cf894811
https://doaj.org/article/b5343f8dc6e245e9b9688295ac08bda0
https://doaj.org/article/b5343f8dc6e245e9b9688295ac08bda0
Autor:
Agnija Rasa, Pēteris Alberts, Linda Brokāne, Andra Tilgase, Donatas Petroška, Evija Olmane, Inta Jaunalksne
Publikováno v:
Clinical Case Reports, Vol 7, Iss 6, Pp 1191-1196 (2019)
Clinical case reports, Hoboken : Wiley-Blackwell Publishing Ltd, 2019, vol. 7, no. 6, p. 1191-1196
Clinical Case Reports
Clinical case reports, Hoboken : Wiley-Blackwell Publishing Ltd, 2019, vol. 7, no. 6, p. 1191-1196
Clinical Case Reports
A 35‐year‐old male patient was diagnosed with stage IIC skin melanoma that rapidly progressed after surgery. Treatment was continued with radiotherapy, which did not stop further spread of disease and the patient was put on a combination of nivol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f41a996c5fa4926bcdddf263fe86b89
https://doaj.org/article/a3498975670446ecb292bde6385c8f1f
https://doaj.org/article/a3498975670446ecb292bde6385c8f1f